[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
CAS: 114-07-8
Ref. IN-DA0039A1
5g | 25,00 € | ||
25g | 52,00 € | ||
100g | 119,00 € | ||
500g | 509,00 € |
Informação sobre produto
- Erycette
- Erymax
- Erythromycin
- Erythromycin A
- Erythromycin C
- Erythromycin Lactate
- Erythromycin Phosphate
- Ilotycin
- Lactate, Erythromycin
- Phosphate, Erythromycin
- Ver mais sinónimos
- T Stat
- T-Stat
- erythromycin
- Erythromycin A
- E-Mycin
- Abomacetin
- Erythrocin
- Erythromycinum
- Erymax
- Ilotycin
- Erythromycine
- Eritromicina
- Emgel
- Robimycin
- Erythro-Statin
- E-Glades
- E-Base
- erythro
- Benzamycin
- Dumotrycin
- Mephamycin
- Eryacne
- Sansac
- Eryc Sprinkles
- Erythra-Derm
- Akne-Mycin
- Erythromycin base
- R-P Mycin
- Wemid
- E-Solve 2
- Torlamicina
- Abboticin
- Erycette
- Ery-Tab
- Erythroguent
- Eritrocina
- Erycinum
- Erythrogran
- Erythromid
- Pantomicina
- Propiocine
- Stiemycin
- Dotycin
- Ermycin
- Erycen
- Erycin
- Eryderm
- Erygel
- Ilocaps
- Aknin
- Pfizer-E
- Theramycin Z
- Kesso-Mycin
- Taimoxin-F
- Ak-Mycin
- Erythromast 36
- Erythromycin Lactate
- T-Stat
- Endoeritrin
- Eritomicina
- Erythroderm
- Erytrociclin
- Paediathrocin
- Pharyngocin
- Proterytrin
- Acneryne
- Acnesol
- Aknemycin
- Derimer
- Deripil
- Erisone
- Eryacnen
- Erydermer
- Eryhexal
- Erysafe
- Iloticina
- Latotryd
- Lederpax
- Mercina
- Oftamolets
- Pantoderm
- Pantodrin
- Primacine
- Romycin
- Stiemicyn
- Tiloryth
- Tiprocin
- Emuvin
- Emycin
- Erecin
- Erymed
- Erytab
- Erytop
- Inderm
- Retcin
- AustriaS
- Eros
- Ery-maxin
- Erythro-Teva
- Sans-acne
- Erimycin-T
- Ery-Diolan
- Inderm Gel
- Del-Mycin
- Wyamycin S
- Aknederm Ery Gel
- Udima Ery Gel
- Emu-Ve
- Erythrocin stearate
- Skid Gel E
- Akne Cordes Losung
- Ilosone (estolate)
- E-Mycin (base)
- Ery-Tab (base)
- E-Base (base)
- Emu-V
- Ery-B
- C-Solve-2
- IndermRetcin
- erythromycin-A
- A/T/S
- Oftalmolosa Cusi Eritromicina
- Ilotycin gluceptate
- (-)-Erythromycin, 98%
- (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione
- Ilotycin T.S.
- (-)-Erythromycin, Eur.Ph.
- N-Methylerythromycin A
- Ery-Sol
- (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3-amino-3,4,6-trideoxy-N,N-dimethyl--D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C,3-O-dimethyl--L-ribo-hexopyranosyloxy)-13-ethyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxotridecan-13-olide
- erthromycin
- Erythromycines
- E-mycin, Erythrocin
- Erythromycin(E-Mycin)
- Erythromycin A, B + C
- Erythromycin (mixture of A,B,C)
- Erythromycin, labeled with carbon-13
- Erythromycin, tested according to Ph.Eur.
- Erythromycin, N-demethyl-N-(methyl-11C)-
- Erythromycin, plant cell culture tested, ~98%
- Erythromycin, Biotechnology Performance Certified
- 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- Erythromycin, Antibiotic for Culture Media Use Only
- Erythromycin, BioReagent, suitable for cell culture
- Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
- (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- (3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- Drmysin
- E-mycin
- E.E.S
- EMU
- Ergel
- Eritocina
- Eritrex
- Eritromed
- Erthrogran
- Ery Derm
- Ery-Ped
- EryDerm
- Eryc
- Erythro
- Erythromast
- Ilocap
- Ilosone
- L-alpha-Egg-phosphatidylcholine
- Nsc 55929
- Oxacyclotetradecane, erythromycin deriv.
- Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
- Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
- P.C.E.
- PCE
- Pediamycin
- Statcin
- Staticin
- Torlamicna
- Vetwic
- Wintrocin
- Wyamycin-s
- [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
Propriedades químicas
Consulta técnica sobre: IN-DA0039A1 [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.